3rd Quarter - Amendment

THE ADVOCACY GROUP for EMERGENT BIOSOLUTIONS

Period 3rd Quarter 2017 Filed Oct 20, 2017 Signed by GEORGE A. RAMONAS

Official filing
Firm
THE ADVOCACY GROUP
Client
EMERGENT BIOSOLUTIONS
Income
$20,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 19, 2017 $20,000 Replaced
3rd Quarter - Amendment (this page) Oct 20, 2017 $20,000 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government. Re-authorization of the Pandemic and All-Hazards Preparedness Act. NDAA - provisions related to biological and chemical defense.

LobbyistCovered position, as disclosed
ROBERT J DOTCHIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS)

Disaster Planning/Emergencies DIS

FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government. Re-authorization of the Pandemic and All-Hazards Preparedness Act. NDAA - provisions related to biological and chemical defense.

LobbyistCovered position, as disclosed
ROBERT J DOTCHIN —

Contacted: SENATE; Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government. Re-authorization of the Pandemic and All-Hazards Preparedness Act. NDAA - provisions related to biological and chemical defense.

LobbyistCovered position, as disclosed
ROBERT J DOTCHIN —

Contacted: HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS); SENATE

Homeland Security HOM

FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government. Re-authorization of the Pandemic and All-Hazards Preparedness Act. NDAA - provisions related to biological and chemical defense.

LobbyistCovered position, as disclosed
ROBERT J DOTCHIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Homeland Security, Dept of (DHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.